May 04, 2023 / 08:30PM GMT
Operator
My name is Kayla Baker, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand First Quarter 2023 Earnings Webcast. (Operator Instructions)
I would now like to turn the call over to Head of Investor Relations, Simon Latimer.
Simon Latimer - Ligand Pharmaceuticals Incorporated - Head of IR
Thanks, Kayla. Welcome to Ligand's first quarter 2023 financial results and business update conference call. Please note that there are slides accompanying today's call. These can be accessed by going to the Investors section of our corporate website, where you can find the link to the webcast on the IR calendar page. Today, when discussing our financial results, we will use non-GAAP financial measures, and some of our statements will be forward looking, including those related to our financial condition, results of operations, financial guidance and the impact of the COVID-19 pandemic. Please review our disclosures about forward-looking statements here on slide 2.
Additional information concerning risk
Q1 2023 Ligand Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot